日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes Network

在全球范围内推进药物公平：来自ASCPT开发、监管和结果网络的思考

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.70237
Jayachandran, Priya; Ladumor, Mayur K; Vlasakakis, Georgios; Riselli, Andrew; Ilic, Katarina V; van Wijk, Rob C; Elmeliegy, Mohamed; Mukker, Jatinder Kaur; Sawant-Basak, Aarti; Long, Tao; Dong, Juyao; Rayad, Noha; Zhang, Tao
ASC
发表日期：2026
文献求助 收藏

The JPET Editorial Fellowship: Opening the Blinds to the Peer Review and Editorial Process

JPET编辑奖学金：揭开同行评审和编辑过程的神秘面纱

期刊:Journal of Pharmacology and Experimental Therapeutics
影响因子:3.8
doi:10.1124/jpet.124.002201
Ladumor, Mayur K; Mielnik, Catharine A; Peterson, Cristina D; Rwere, Freeborn; Gross, Eric R
发表日期：2024
文献求助 收藏

Toward improved predictions of pharmacokinetics of transported drugs in hepatic impairment: Insights from the extended clearance model

提高肝功能损害患者转运药物药代动力学预测的准确性：来自扩展清除模型的启示

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13062
Storelli, Flavia; Ladumor, Mayur K; Liang, Xiaomin; Lai, Yurong; Chothe, Paresh P; Enogieru, Osatohanmwen J; Evers, Raymond; Unadkat, Jashvant D
发表日期：2024
文献求助 收藏

A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children

健康成人、肝功能不全成人和儿童中大麻二酚的生理药代动力学模型

期刊:Drug Metabolism and Disposition
影响因子:4.4
doi:10.1124/dmd.122.001128
Sumit Bansal, Mayur K Ladumor, Mary F Paine, Jashvant D Unadkat
信号转导
发表日期：2023
文献求助 收藏

Predicting changes in the pharmacokinetics of CYP3A-metabolized drugs in hepatic impairment and insights into factors driving these changes

预测肝功能损害时CYP3A代谢药物的药代动力学变化，并深入了解驱动这些变化的因素。

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.12901
Ladumor, Mayur K; Storelli, Flavia; Liang, Xiaomin; Lai, Yurong; Enogieru, Osatohanmwen J; Chothe, Paresh P; Evers, Raymond; Unadkat, Jashvant D
代谢
发表日期：2023
文献求助 收藏

Vitamin D Receptor Activation Attenuates Hippo Pathway Effectors and Cell Survival in Metastatic Neuroblastoma

维生素D受体激活减弱Hippo通路效应因子和转移性神经母细胞瘤细胞存活

期刊:Molecular Cancer Research
影响因子:4.7
doi:10.1158/1541-7786.MCR-21-0425
Ladumor, Yagnesh; Seong, Bo Kyung Alex; Hallett, Robin; Valencia-Sama, Ivette; Adderley, Teresa; Wang, Yingying; Kee, Lynn; Gont, Alexander; Kaplan, David R; Irwin, Meredith S
信号转导
细胞生物学
Hippo
发表日期：2022
文献求助 收藏

Recent advances made in the synthesis of small drug molecules for clinical applications: An insight

近年来，用于临床应用的小分子药物合成领域取得了哪些进展：一些见解

期刊:Drug Metabolism and Disposition
影响因子:4
doi:10.1124/dmd.121.000733
Peng, Jinfu; Ladumor, Mayur K; Unadkat, Jashvant D; Arora, Gunjan; Shrivastava, Ruchi; Kumar, Prashant; Bandichhor, Rakeshwar; Krishnamurthy, Dhileep; Sharma, Rakesh Kumar; Matharu, Avtar S; Pandey, Jaya; Rizwan, Mohammad
发表日期：2021
文献求助 收藏

Prediction of Pregnancy-Induced Changes in Secretory and Total Renal Clearance of Drugs Transported by Organic Anion Transporters

预测妊娠引起的有机阴离子转运蛋白转运药物的分泌清除率和总肾清除率的变化

期刊:Drug Metabolism and Disposition
影响因子:4
doi:10.1124/dmd.121.000557
Peng, Jinfu; Ladumor, Mayur K; Unadkat, Jashvant D
发表日期：2021
文献求助 收藏

Imaging features of fungal pneumonia in haematopoietic stem cell transplant patients

造血干细胞移植患者真菌性肺炎的影像学特征

期刊:
影响因子:
doi:10.5114/pjr.2021.107057
Revels, Jonathan W; Fadl, Shaimaa A; Wang, Sherry S; Ladumor, Heta; Xu, Haodong; Kicska, Gregory
肺炎
发育与干细胞
微生物学
干细胞
细胞生物学
发表日期：2021
文献求助 收藏

NRAS Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS-MAPK Pathway in Neuroblastoma

NRAS 状态决定神经母细胞瘤对针对 RAS-MAPK 通路的 SHP2 抑制剂联合疗法的敏感性

期刊:Cancer Research
影响因子:12.5
doi:10.1158/0008-5472.CAN-19-3822
Ivette Valencia-Sama, Yagnesh Ladumor, Lynn Kee, Teresa Adderley, Gabriella Christopher, Claire M Robinson, Yoshihito Kano, Michael Ohh, Meredith S Irwin
信号转导
神经
其它细胞
MAPK/ERK
Neuroscience
发表日期：2020
文献求助 收藏